Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression
May 20, 2026
May 20, 2026
BRISTOL, England, May 20 -- The University of Bristol issued the following news release:
* * *
Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression
*
Researchers investigated, for the first time, whether tocilizumab, an existing anti-inflammatory drug commonly used to treat immune conditions such as rheumatoid arthritis, could improve symptoms of depression in people who have not responded to standard antidepress . . .
* * *
Pilot trial suggests anti-inflammatory drug could help difficult-to-treat depression
*
Researchers investigated, for the first time, whether tocilizumab, an existing anti-inflammatory drug commonly used to treat immune conditions such as rheumatoid arthritis, could improve symptoms of depression in people who have not responded to standard antidepress . . .